Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy-Reference-Cited by-同舟云学术

Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy

Published:2022-11 Issue: Volume:Volume 16 Page:4061-4076
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Zhang Ping Na,Tang Jing Yi,Yang Ke Zhen,Zheng Qi Yan,Dong Zhao Cheng,Geng Yun Ling,Liu Yu Ning,Liu Wei Jing^ORCID

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference38 articles.

1. Molecular Pathogenesis of Membranous Nephropathy

2. M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

3. Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy

4. Primary Membranous Nephropathy

5. Membranous nephropathy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of network pharmacology in synergistic action of Chinese herbal compounds;Theory in Biosciences;2024-06-18

2. Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives;Journal of Nanobiotechnology;2024-01-03

4. Network pharmacology-based approach to understand the effect and mechanism of chrysophanol against cognitive impairment in Wilson disease;Metabolic Brain Disease;2023-11-24

5. Network pharmacology and molecular docking predictions of the active compounds and mechanism of action of Huangkui capsule for the treatment of idiopathic membranous nephropathy;Medicine;2023-09-15